Open Access

Use of GDF-15 in the management of patients with ACS.

Presentation

About the speaker

Professor Lars Wallentin

Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala (Sweden)
14 presentations
0 follower

3 more presentations in this session

Introduction - How to use biomarkers to optimize diagnosis and risk stratification of ACS.

Speaker: Professor H. Katus (Heidelberg, DE) Professor C. Mueller (Basel, CH)

Thumbnail

Benefits of the 1-hour algorithm for the diagnosis of acute myocardial infarction (AMI) using cardiac troponin T -high sensitive.

Speaker: Professor C. Mueller (Basel, CH)

Thumbnail

Do cardiac troponin T -high sensitive gender specific cut-offs lead to different treatment strategy for the diagnosis of AMI?

Speaker: Assistant Professor E. Giannitsis (Heidelberg, DE)

Thumbnail

Access the full session

How to use biomarkers to optimize diagnosis and risk stratification of acute coronary syndrome (ACS)

Speakers: Professor L. Wallentin, Professor H. Katus, Professor C. Mueller, Professor C. Mueller, Assistant Professor E. Giannitsis
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

Related content

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

When is ablation the preferred approach to treat atrial fibrillation?

27 August 2021

This platform is supported by

logo Novo Nordisk